Using translational in vitro-in vivo modeling to improve drug repurposing outcomes for inhaled COVID-19 therapeutics
Madison Stoddard, Lin Yuan, Arijit Chakravarty
doi: https://doi.org/10.1101/2021.03.11.21253375
Madison Stoddard
1Fractal Therapeutics Inc, Cambridge, MA, USA
Lin Yuan
1Fractal Therapeutics Inc, Cambridge, MA, USA
Arijit Chakravarty
1Fractal Therapeutics Inc, Cambridge, MA, USA
Data Availability
The work describes a mathematical methodology based on publicly available data. All data used in the work was sourced from prior publications.
Posted March 12, 2021.
Using translational in vitro-in vivo modeling to improve drug repurposing outcomes for inhaled COVID-19 therapeutics
Madison Stoddard, Lin Yuan, Arijit Chakravarty
medRxiv 2021.03.11.21253375; doi: https://doi.org/10.1101/2021.03.11.21253375
Subject Area
Subject Areas
- Addiction Medicine (324)
- Allergy and Immunology (628)
- Anesthesia (165)
- Cardiovascular Medicine (2377)
- Dermatology (207)
- Emergency Medicine (379)
- Epidemiology (11775)
- Forensic Medicine (10)
- Gastroenterology (703)
- Genetic and Genomic Medicine (3744)
- Geriatric Medicine (350)
- Health Economics (634)
- Health Informatics (2399)
- Health Policy (933)
- Hematology (341)
- HIV/AIDS (782)
- Medical Education (365)
- Medical Ethics (105)
- Nephrology (398)
- Neurology (3507)
- Nursing (198)
- Nutrition (526)
- Oncology (1824)
- Ophthalmology (538)
- Orthopedics (219)
- Otolaryngology (287)
- Pain Medicine (233)
- Palliative Medicine (66)
- Pathology (446)
- Pediatrics (1035)
- Primary Care Research (420)
- Public and Global Health (6145)
- Radiology and Imaging (1280)
- Respiratory Medicine (828)
- Rheumatology (379)
- Sports Medicine (323)
- Surgery (402)
- Toxicology (50)
- Transplantation (172)
- Urology (146)